韩国住院COVID-19患者淋巴细胞亚群计数与疾病严重程度和SARS-CoV-2变异的差异

IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Heayeon Lee, Bora Lee, Sei Won Kim, Chang Dong Yeo, Sang Haak Lee, Jihyang Lim
{"title":"韩国住院COVID-19患者淋巴细胞亚群计数与疾病严重程度和SARS-CoV-2变异的差异","authors":"Heayeon Lee, Bora Lee, Sei Won Kim, Chang Dong Yeo, Sang Haak Lee, Jihyang Lim","doi":"10.3346/jkms.2025.40.e172","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The studies about the characteristics of immune systems and lymphocyte subset counts regarding coronavirus disease 2019 (COVID-19) have been conducted in a number of ways, however studies on the difference of lymphocyte subset counts according to each severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant are rare. As each country has a different quarantine system, it is necessary to investigate the characteristics in places such as South Korea where the vaccination rate is high and a thorough national quarantine system is being operated. The aim of this study was to investigate the difference in peripheral blood lymphocyte subset counts in COVID-19 patients in South Korea according to their disease severity and SARS-CoV-2 variants.</p><p><strong>Methods: </strong>A total of 148 hospitalized COVID-19 patients enrolled in this study at Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea. SARS-CoV-2 infection was confirmed using real-time quantitative polymerase chain reaction and COVID-19 severity was divided into three groups (mild, moderate, and severe) at the time of admission, according to the treatment types of oxygen support. Laboratory tests were performed for evaluation of inflammatory status. The peripheral lymphocyte subset counts were analyzed using flow cytometry at the time of admission in all 148 patients and after treatment in 65 patients with moderate or severe severity. We analyzed the changes of peripheral lymphocyte subset counts according to three COVID-19 severity groups and three SARS-CoV-2 variants (wild and alpha, delta and omicron variants).</p><p><strong>Results: </strong>At admission, total T, CD4+ T, CD8+ T, natural killer (NK), and NKT cell counts decreased, but B cells did not change significantly depending on severity. There were markedly decreased in total T, CD4+ T, CD8+ T, and NK cells in the delta and omicron variants and not in the wild and alpha variant. After treatment in patients with moderate or severe severity, most lymphocyte subset counts were increased except the NK cells. Lower total lymphocyte counts, especially total T lymphocyte counts were associated with a higher occurrence of severe COVID-19.</p><p><strong>Conclusion: </strong>The peripheral lymphocyte subset counts decreased according to disease severity and the types of SARS-CoV-2 variants in hospitalized COVID-19 patients. Despite the efficient operation of the national quarantine system and high vaccination rates in South Korea, it suggests that viral mutations evolve in a direction that further weakens the immune system. This is the only study on the difference in peripheral lymphocyte subset counts according to COVID-19 severity and SARS-CoV-2 variants conducted in South Korea, and therefore our data could be used as an important reference for another pandemic situation in the future.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 29","pages":"e172"},"PeriodicalIF":2.3000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12303659/pdf/","citationCount":"0","resultStr":"{\"title\":\"Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.\",\"authors\":\"Heayeon Lee, Bora Lee, Sei Won Kim, Chang Dong Yeo, Sang Haak Lee, Jihyang Lim\",\"doi\":\"10.3346/jkms.2025.40.e172\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The studies about the characteristics of immune systems and lymphocyte subset counts regarding coronavirus disease 2019 (COVID-19) have been conducted in a number of ways, however studies on the difference of lymphocyte subset counts according to each severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant are rare. As each country has a different quarantine system, it is necessary to investigate the characteristics in places such as South Korea where the vaccination rate is high and a thorough national quarantine system is being operated. The aim of this study was to investigate the difference in peripheral blood lymphocyte subset counts in COVID-19 patients in South Korea according to their disease severity and SARS-CoV-2 variants.</p><p><strong>Methods: </strong>A total of 148 hospitalized COVID-19 patients enrolled in this study at Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea. SARS-CoV-2 infection was confirmed using real-time quantitative polymerase chain reaction and COVID-19 severity was divided into three groups (mild, moderate, and severe) at the time of admission, according to the treatment types of oxygen support. Laboratory tests were performed for evaluation of inflammatory status. The peripheral lymphocyte subset counts were analyzed using flow cytometry at the time of admission in all 148 patients and after treatment in 65 patients with moderate or severe severity. We analyzed the changes of peripheral lymphocyte subset counts according to three COVID-19 severity groups and three SARS-CoV-2 variants (wild and alpha, delta and omicron variants).</p><p><strong>Results: </strong>At admission, total T, CD4+ T, CD8+ T, natural killer (NK), and NKT cell counts decreased, but B cells did not change significantly depending on severity. There were markedly decreased in total T, CD4+ T, CD8+ T, and NK cells in the delta and omicron variants and not in the wild and alpha variant. After treatment in patients with moderate or severe severity, most lymphocyte subset counts were increased except the NK cells. Lower total lymphocyte counts, especially total T lymphocyte counts were associated with a higher occurrence of severe COVID-19.</p><p><strong>Conclusion: </strong>The peripheral lymphocyte subset counts decreased according to disease severity and the types of SARS-CoV-2 variants in hospitalized COVID-19 patients. Despite the efficient operation of the national quarantine system and high vaccination rates in South Korea, it suggests that viral mutations evolve in a direction that further weakens the immune system. This is the only study on the difference in peripheral lymphocyte subset counts according to COVID-19 severity and SARS-CoV-2 variants conducted in South Korea, and therefore our data could be used as an important reference for another pandemic situation in the future.</p>\",\"PeriodicalId\":16249,\"journal\":{\"name\":\"Journal of Korean Medical Science\",\"volume\":\"40 29\",\"pages\":\"e172\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-07-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12303659/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Korean Medical Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3346/jkms.2025.40.e172\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3346/jkms.2025.40.e172","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:关于2019冠状病毒病(COVID-19)的免疫系统特征和淋巴细胞亚群计数的研究已经有很多,但关于各严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)变异的淋巴细胞亚群计数差异的研究很少。各国的防疫制度各不相同,因此有必要调查像韩国这样防疫率高、实行全面防疫制度的国家的特点。本研究的目的是研究韩国COVID-19患者外周血淋巴细胞亚群计数根据疾病严重程度和SARS-CoV-2变体的差异。方法:选取韩国天主教大学医学院恩平圣母医院新冠肺炎住院患者148例为研究对象。采用实时定量聚合酶链反应确诊SARS-CoV-2感染,并根据氧支持治疗方式将入院时COVID-19严重程度分为轻、中、重度3组。进行实验室检查以评估炎症状态。采用流式细胞术分析148例患者入院时和65例中度或重度患者治疗后的外周血淋巴细胞亚群计数。我们根据三个COVID-19严重程度组和三种SARS-CoV-2变体(野生型和α型、δ型和组粒型)分析外周血淋巴细胞亚群计数的变化。结果:入院时,总T、CD4+ T、CD8+ T、自然杀伤细胞(NK)和NKT细胞计数下降,但B细胞计数无明显变化。δ型和组粒型的总T细胞、CD4+ T细胞、CD8+ T细胞和NK细胞明显减少,而α型和野生型则无明显减少。中度或重度患者治疗后,除NK细胞外,大多数淋巴细胞亚群计数均升高。较低的总淋巴细胞计数,特别是总T淋巴细胞计数与较高的重症COVID-19发生率相关。结论:COVID-19住院患者外周血淋巴细胞亚群计数随病情严重程度和SARS-CoV-2变异类型的不同而降低。尽管韩国的国家检疫系统运行效率很高,疫苗接种率也很高,但这表明病毒突变的方向是进一步削弱免疫系统。这是韩国唯一一项根据COVID-19严重程度和SARS-CoV-2变异对外周血淋巴细胞亚群计数差异的研究,因此我们的数据可以作为未来另一次大流行情况的重要参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.

Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.

Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.

Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.

Background: The studies about the characteristics of immune systems and lymphocyte subset counts regarding coronavirus disease 2019 (COVID-19) have been conducted in a number of ways, however studies on the difference of lymphocyte subset counts according to each severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant are rare. As each country has a different quarantine system, it is necessary to investigate the characteristics in places such as South Korea where the vaccination rate is high and a thorough national quarantine system is being operated. The aim of this study was to investigate the difference in peripheral blood lymphocyte subset counts in COVID-19 patients in South Korea according to their disease severity and SARS-CoV-2 variants.

Methods: A total of 148 hospitalized COVID-19 patients enrolled in this study at Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea. SARS-CoV-2 infection was confirmed using real-time quantitative polymerase chain reaction and COVID-19 severity was divided into three groups (mild, moderate, and severe) at the time of admission, according to the treatment types of oxygen support. Laboratory tests were performed for evaluation of inflammatory status. The peripheral lymphocyte subset counts were analyzed using flow cytometry at the time of admission in all 148 patients and after treatment in 65 patients with moderate or severe severity. We analyzed the changes of peripheral lymphocyte subset counts according to three COVID-19 severity groups and three SARS-CoV-2 variants (wild and alpha, delta and omicron variants).

Results: At admission, total T, CD4+ T, CD8+ T, natural killer (NK), and NKT cell counts decreased, but B cells did not change significantly depending on severity. There were markedly decreased in total T, CD4+ T, CD8+ T, and NK cells in the delta and omicron variants and not in the wild and alpha variant. After treatment in patients with moderate or severe severity, most lymphocyte subset counts were increased except the NK cells. Lower total lymphocyte counts, especially total T lymphocyte counts were associated with a higher occurrence of severe COVID-19.

Conclusion: The peripheral lymphocyte subset counts decreased according to disease severity and the types of SARS-CoV-2 variants in hospitalized COVID-19 patients. Despite the efficient operation of the national quarantine system and high vaccination rates in South Korea, it suggests that viral mutations evolve in a direction that further weakens the immune system. This is the only study on the difference in peripheral lymphocyte subset counts according to COVID-19 severity and SARS-CoV-2 variants conducted in South Korea, and therefore our data could be used as an important reference for another pandemic situation in the future.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Korean Medical Science
Journal of Korean Medical Science 医学-医学:内科
CiteScore
7.80
自引率
8.90%
发文量
320
审稿时长
3-6 weeks
期刊介绍: The Journal of Korean Medical Science (JKMS) is an international, peer-reviewed Open Access journal of medicine published weekly in English. The Journal’s publisher is the Korean Academy of Medical Sciences (KAMS), Korean Medical Association (KMA). JKMS aims to publish evidence-based, scientific research articles from various disciplines of the medical sciences. The Journal welcomes articles of general interest to medical researchers especially when they contain original information. Articles on the clinical evaluation of drugs and other therapies, epidemiologic studies of the general population, studies on pathogenic organisms and toxic materials, and the toxicities and adverse effects of therapeutics are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信